2019 • 2018 • 2017 • 2016 • 2015 • 2014 • 2013 • 2012 • 2011 • 2010
2009 • 2008 • 2007 • 2006 • 2005 • 2004 • 2003 • 2002 • 2001 • 2000
— 2004 —
Carr K, HenchalEA , Wilhelmsen C, Carr B. 2004. Implementation of biosurety systems in a department of defense medical research laboratory. Biosecur Bioterror 2:1-16.
Hale ML, Marvaud J-C, Popoff MR, Stiles BG. 2004. Detergent-resistant membrane microdomains facilitate Ib oligomerization formation and biological activity of Clostridium perfringens iota toxin. Infect Immun 72: 2186-2193.
Hartings JM, Roy CJ. 2004. The automated bioaerosol exposure system: preclinical platform development and a dosimetry application with nonhuman primates. J Pharmacol Toxicol Methods 49:39-55.
Hensley LE, Fritz EA, Jahrling PB, Geisbert TW. 2004. Interferon-beta 1a and SARS coronavirus replication. Emerg Infect Dis 10:317-319.
Hering D, Thompson W, Hewetson J, Little S, Norris S, Pace-Templeton J. 2004. Validation of the anthrax lethal toxin neutralization assay. Biologicals 32:17-27.
Hevey M, Negley D, Schmaljohn A. 2004. Characterization of monoclonal antibodies to Marburg virus (strain Musoke) glycoprotein and identification of two protective epitopes. Virology 314:350-357.
Hooper JW, Thompson E, Wilhelmsen C, Zimmerman M, Ait-Ichou M, Steffan S, Schmaljohn CS, Schmaljohn AL, Jahrling PB. 2004. Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox. J Virol 78:4433-4443.
Hurtle W, Bode E, Kulesh DA, Kaplan RS, Garrison J, Bridge D, House M, Frye MS, Loveless B, Norwood D. 2004. Detection of the Bacillus anthracis gyrA gene by using a minor groove binder probe. J Clin Microbiol 42:179-185.
Lebeda FJ. 2004. BOTDB: a database resource for the clostridial neurotoxins. Mov Disord 19:S35-S41.
Jarrett CO, Sebbane F, Adamovicz JJ, Andrews GP, Hinnebusch BJ. 2004. A flea-borne transmission model to evaluate vaccine efficacy against naturally acquired bubonic plague. Infect Immun 72:2052-2056.
Kulesh DA, Baker RO, Loveless B, Norwood D, Zwiers SH, Mucker E, Hartmann C, Herrera R, Miller D, Christensen D, Wasieloski Jr LP, Huggins J, Jahrling PB. 2004. Smallpox and pan-orthopox virus detection by real-time 3'-minor groove binder TaqMan assays on the roche LightCycler and the Cepheid smart Cycler platforms. J Clin Microbiol 42:601-609.
Little SF, Ivins BE, Fellows PF, Pitt MLM, Norris SLW, Andrews GP. 2004. Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine. Vaccine 22:422-430.
Matyas GR, Rao M, Pittman PR, Burge R, Robbins IE, Wassef NM, Thiverge B, Alving CR. 2004. Detection of antibodies to squalene III. Naturally occurring antibodies to squalene in humans and mice. J Immunol Methods 286:47-67.
O’Guinn ML, Lee JS, Kondig JP, Fernandez R, Carbajal F. 2004. Field detection of eastern equine encephalitis virus in the Amazon Basin region of Peru using reverse transcription-polymerase chain reaction adapted for field identification of arthropod-borne pathogens. Am J Trop Med Hyg 70:164-171.
Panchal RG, Hermone AR, Nguyen TL, Wong TY, Schwarzenbacher R, Schmidt J, Lane D, McGrath C, Turk BE, Burnett J, Aman MJ, Little S, Sausaville EA, Zaharevitz DW, Cantley LC, Liddington RC, Gussio R, Bavari S. 2004. Identification of small molecule inhibitors of anthrax lethal toxin. Nat Struct Mol Biol 11:67-72.
Panchal RG, Ruthel G, Kenny TA, Kallstrom GH, Lane D, Badie SS, Li L, Bavari S, Aman MJ. 2004. In vivo oligomerization and raft localization of Ebola VP40 during vesicular budding. Proc Natl Acad Sci 100:15936-15941.
Reed DS, Lind CM, Sullivan LJ, Pratt WD, Parker MD. 2004. Aerosol infection of cynomolgus macaques with enzootic strains of Venezuelan equine encephalitis viruses. J Infect Dis 189:1013-1017.
Rusnak J, Boudreau E, Bozue J, Pettit P, Ranadive M, Kortepeter M. 2004. An unusual inhalational exposure to Bacillus anthracis in a research laboratory. Letter to the editor, J Occup Environ Med 46:313-314.
Ruthel G, Ribot WJ, Bavari S, Hoover TA. 2004. Time-lapse confocal imaging of development of Bacillus anthracis in macrophages. J Infect Dis 189:1313-1316.
Smith LA, Jensen MJ, Montgomery VA, Brown DR, Ahmed SA, Smith TJ. 2004. Roads from vaccines to therapies. Mov Disord 19:S48-S52.
Swenson DL, Warfield KL, Kuehl K, Larsen T, Hevey MC, Schmaljohn A, Bavari S, Aman MJ. 2004. Generation of Marburg virus-like particles by co-expression of glycoprotein and matrix protein. FEMS Immunol Med Microbiol 40:27-31.
Ulrich RL, DeShazer D. 2004. Type III secretion: a virulence factor delivery system essential for the pathogenicity of Burkholderia mallei. Infect Immun 72:1150-1154.
Welkos SL, Cote CK, Rea KM, Gibbs PH. 2004. A microtiter fluorometric assay to detect the germination of Bacillus anthracis spores and the germination inhibitory effects of antibodies. J Microbiol Meth 56;253-265.
|
SITEMAP
ARMY.MIL 
